2026 2H Healthcare Dividend Roundup: Johnson & Johnson Outshines AbbVie (NYSE:ABBV)
2026 2H Healthcare Dividend Roundup: Johnson & Johnson Outshines AbbVie (NYSE:ABBV) Seeking Alpha
Covered in this story
What has happened since
- AbbVie is up 0.8% since this was published, 5 days ago.
- Johnson & Johnson is up 1.1% since this was published, 5 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $ABBV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on AbbVie →Dalsna Finance is currently tracking 52 stories mentioning AbbVie, the earliest published 19 Mar 2026.
Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.